TY  - GEN
AU  - Haas-Kogan,Daphne A
AU  - Prados,Michael D
AU  - Tihan,Tarik
AU  - Eberhard,David A
AU  - Jelluma,Nannette
AU  - Arvold,Nils D
AU  - Baumber,Rachel
AU  - Lamborn,Kathleen R
AU  - Kapadia,Ami
AU  - Malec,Mary
AU  - Berger,Mitchel S
AU  - Stokoe,David
TI  - Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib
SN  - 1460-2105
PY  - 2005///0712
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Area Under Curve
KW  - Dacarbazine
KW  - Drug Administration Schedule
KW  - Drug Resistance, Neoplasm
KW  - ErbB Receptors
KW  - drug effects
KW  - Erlotinib Hydrochloride
KW  - Female
KW  - Glioma
KW  - drug therapy
KW  - Humans
KW  - Immunohistochemistry
KW  - In Situ Hybridization, Fluorescence
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - PTEN Phosphohydrolase
KW  - Phosphoric Monoester Hydrolases
KW  - Phosphorylation
KW  - Protein Serine-Threonine Kinases
KW  - antagonists & inhibitors
KW  - Proto-Oncogene Proteins
KW  - Proto-Oncogene Proteins c-akt
KW  - Quinazolines
KW  - Supratentorial Neoplasms
KW  - Temozolomide
KW  - Tumor Suppressor Proteins
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1093/jnci/dji161
ER  -